HCWB HCW Biologics Inc
Company Analysis
Latest News
🔴 HCW Biologics is trading 5% down today amid AI-spending concerns weighing on growth stocks
HCW Biologics is trading at $1.10, down 5.14%, amid a broader risk-off session. - Technology shares faced pressure from AI-spending concerns, while rising oil...
🟢 HCW Biologics is trading 6% up in pre-market with biotech strength offering possible support
HCW Biologics is trading at $1.23, up 6.03%, with biotech-sector gains offering possible support, though the catalyst remains uncertain. - No new...
🟢 HCW Biologics is trading 9.4% up in pre-market as catalyst remains unclear
HCW Biologics is trading 9.4% up at $1.28 in pre-market; the reason for the move is unclear. - No new company-specific announcement for October 21 was...
🟢 HCW Biologics is trading 6.7% up in pre-market
HCW Biologics is trading at $1.31, up +6.73%, with no clear catalyst identified for its pre-market move. - No company-specific announcement for October 20 was...
🟢 HCW Biologics is trading 7% up today amid biotech-sector gains
HCW Biologics is trading at $1.33, up 7.26%, amid biotech-sector strength; no company-specific catalyst was identified. - The price is up from the October 16...
🟢 HCW Biologics is trading 14% up in pre-market; catalyst remains unclear
HCW Biologics is trading at $1.41, up +13.98%, with the specific catalyst unclear. - No new company-specific announcement was identified for October 19. The...
🟢 HCW Biologics is trading 5.7% up in pre-market with no clear company-specific catalyst
HCW Biologics is trading at $1.30, up 5.7% in pre-market, with no clear company-specific catalyst identified. - That compares with $1.23 at the October 15...
🟢 HCW Biologics is trading 11% up in pre-market; no clear catalyst identified
HCW Biologics is trading at $1.36, up 10.6%, with no clear reason identified for the pre-market gain. - No HCW Biologics-specific announcement for October 16...
🟢 HCW Biologics is trading 9.4% up
HCW Biologics is trading at $1.28, up 9.36%, with the precise catalyst unclear. - No HCW Biologics-specific announcement for October 15 was confirmed. - Its...
🟢 HCW Biologics is trading 9.4% up in pre-market
HCW Biologics is trading at $1.28, up 9.40%, in pre-market; the immediate catalyst is unclear. - No confirmed company-specific catalyst was identified for the...
🟢 HCW Biologics is trading 5% up in after-hours trading
HCW Biologics is trading at $1.23, up 5.13%, with no confirmed company-specific catalyst identified for the after-hours rise. - Shares closed the regular...
🔴 HCW Biologics is trading 5% down today with no confirmed company-specific catalyst
HCW Biologics is trading 5.16% lower at $1.20, with no verified company-specific catalyst identified for October 14. - The biotech sector is also weaker, with...
🟢 HCW Biologics is trading 5.56% up in after-hours trading
HCW Biologics is trading at $1.33, up 5.56% after hours, with no verified October 13 announcement or other clear catalyst identified. - It closed the regular...
🔴 HCW Biologics is trading 10% down
HCW Biologics is trading at $1.33, down 10.13% on October 13, 2026; no clear announcement explains the decline. - October 9 company news described FDA...
🔴 HCW Biologics is trading 8.1% down
HCW Biologics is trading at $1.36, down 8.09%, with no specific company announcement identified to explain the October 13 decline. - The latest reported...
🔴 HCW Biologics is trading 10.1% down in pre-market
HCW Biologics is trading at $1.33, down 10.1%, with no company-specific explanation identified for the pre-market decline. - This compares with the provided...
🔴 HCW Biologics is trading 6.8% down in pre-market; catalyst unconfirmed
HCW Biologics is trading 6.8% down at $1.38 in pre-market on October 13, 2026, versus the provided previous close of $1.48; the catalyst remains unconfirmed. -...
🔴 HCW Biologics is trading 6% down — reason unconfirmed
HCW Biologics is trading at $1.51, down 5.63%, during the October 12, 2026 session; the reason for the decline remains unconfirmed. - No company-specific...
HCW Biologics Gets FDA Roadmap for Cancer Drug — But Can a $25 Million Company Survive the Journey to the Clinic?
Shares of HCW Biologics surged 13% to $1.73 after the company disclosed that the FDA provided formal guidance on how to advance its lead cancer drug candidate...
🟢 HCW Biologics is trading 13% up today after FDA guidance on cancer-study IND next steps
HCW Biologics is trading at $1.73 (+12.95%) after a recent FDA Type B meeting provided guidance on next steps for a first-in-human solid-tumor study. - The...